Somatostatin Receptor-Targeted Anti-Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|8|1|2-10

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.8, Iss.1, 2011-01, pp. : 2-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: Receptor-Targeted Cancer Therapy (Guest Editor: Li-Chun Sun)]

By  

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Folate Receptor Targeted Liposomes Encapsulating Anti-Cancer Drugs

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 4, 2015-04 ,pp. : 333-343

Bentham Science Publishers

Access to resources Recommend Favorite

Investigation of cancer cell lines for peptide receptor-targeted drug development

By Sun Lichun   Luo Jing   Mackey L. Vienna   Morris Lynsie M.   Franko-Tobin Laura G.   LePage Keith T.   Coy David H.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 719-730

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging

By  

Current Medicinal Chemistry, Vol. 19, Iss. 28, 2012-10 ,pp. : 4742-4758

Bentham Science Publishers

Access to resources Recommend Favorite